KOREY MARSHALL: Open Payments
NPI 1902362627 · LATHAM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$668 in 34 payments from 16 companies in 2025. Trend: 2023 $140 · 2024 $744 · 2025 $668
Food & beverage: $668
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $175 |
| Novo Nordisk Inc | 4 | $87 |
| Galderma Laboratories, L.P. | 4 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $60 |
| ABBVIE INC. | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $19 |
Products named: AIRSUPRA, Wegovy, TRINTELLIX, DYSPORT, Kerendia, QULIPTA, REXULTI, BREZTRI.
Industry payments across NY — which companies pay providers there.
